Impact of adverse events of adjuvant and neoadjuvant chemotherapies on outcomes of patients with pancreatic ductal adenocarcinoma-Reference-Cited by-同舟云学术

Impact of adverse events of adjuvant and neoadjuvant chemotherapies on outcomes of patients with pancreatic ductal adenocarcinoma

Published:2021-04-07 Issue:1 Volume:88 Page:109-120
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Mori Shozo^ORCID,Aoki Taku,Sakuraoka Yuhki,Shimizu Takayuki,Yamaguchi Takamune,Park Kyung-Hwa,Matsumoto Takatsugu,Shiraki Takayuki,Iso Yukihiro,Kubota Keiichi

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s00280-021-04267-5.pdf

Reference30 articles.

1. Versteijne E, Vogel JA, Besselink MG, Busch ORC, Wilmink JW, Daams JG, Dutch Pancreatic Cancer Group et al (2018) Meta-analysis comparing upfront surgery with neoadjuvant treatment in patients with resectable or borderline resectable pancreatic cancer. Br J Surg 105:946–958

2. Egawa S, Toma H, Ohigashi H, Okusaka T, Nakao A, Hatori T et al (2012) Japan Pancreatic Cancer Registry; 30th year anniversary: Japan Pancreas Society. Pancreas 41:985–992

3. Oettle H, Post S, Neuhaus P, Gellert K, Langrehr J, Ridwelski K et al (2007) Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA 297:267–277

4. Oettle H, Neuhaus P, Hochhaus A, Hartmann JT, Gellert K, Ridwelski K et al (2013) Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial. JAMA 310:1473–1481

5. Maeda A, Boku N, Fukutomi A, Kondo S, Kinoshita T, Nagino M et al (2008) Randomized phase III trial of adjuvant chemotherapy with gemcitabine versus S-1 in patients with resected pancreatic cancer: Japan Adjuvant Study Group of Pancreatic Cancer (JASPAC-01). Jpn J Clin Oncol 38:227–229

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neoadjuvant and Adjuvant Chemotherapy for Pancreatic Adenocarcinoma: Literature Review and Our Experience of NAC-GS;Cancers;2024-02-23

2. Efficacy and Feasibility of Adjuvant Gemcitabine Plus Cisplatin Chemotherapy After Major Hepatectomy for Biliary Tract Cancer;Anticancer Research;2021-09-30